Cyclooxygenase-2 2765 G/C polymorphisms and susceptibility to hepatitis B-related liver cancer in Han Chinese population

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 4163-4168

  He, Jianhong ^a   Zhang, Quanbao ^a   Ren, Zhijian ^a,b   Li, Yumin ^a,b   Li, Xun ^a   Zhou, Wence ^a   Zhang, Hui ^a   Meng, Wenbo ^a   Yan, Jun ^a   He, Wenting ^a  

^a LANZHOU UNIVERSITY   (China)

^b Key Laboratory of Digestive System Tumors   (China)

Author keywords

Cyclooxygenase 2; Hepatitis B related liver cancer; Polymorphisms

Indexed keywords

CYCLOOXYGENASE 2; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HEPATITIS B; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; LIVER CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; CASE CONTROL STUDY; CHINA; DEMOGRAPHY; DRINKING BEHAVIOR; ENZYMOLOGY; ETHNIC GROUP; FAMILY; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED; POPULATION GENETICS; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CYCLOOXYGENASE 2; DEMOGRAPHY; ETHNIC GROUPS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84862999937     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1199-y     Document Type: Article

References (26)

1. Parkin DM, Whelan SL, Ferlay J, Storm HH (2005) Cancer incidence in five continents, vols I-VIII. IARC CancerBase No. 7. International Agency for Research on Cancer, Lyon
2. Zhang JY, Dai M, Wang X et al (1998) A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol 27:574-578
3. Mizrak D, Engin B, Onder FO et al (2009) Aflatoxin exposure in viral hepatitis patients in Turkey. Turk J Gastroenterol 20: 192-197
4. Meng W, Lu H, Cai R, Jiang F, Jiang Q, Lin W et al (2002) A study on the genetic epidemiology of hepatocellular carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi 23:438-440 (in Chinese
5. The national treatment and prevention project from 2006 to 2010. Health Department of Gans Province. 2006
6. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B (2009) Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma. Mutat Res 663:52-59
7. Pereira C, Sousa H, Ferreira P, Fragoso M, Moreira-Dias L, Lopes C et al (2006) 765 G[C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World J Gastroenterol 12: 5473-5478
8. Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G et al (2009) MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 315:1439-1447
9. Li F, Ren GS, Li HY, Wang XY, Chen L, Li J (2009) A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer. Clin Oncol (R Coll Radiol) 21: 302-305
10. Shiota G, Okubo M, Noumi T et al (1999) Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology 46:407-412
11. Giannitrapani L, Ingrao S, Soresi M, Florena AM, La Spada E, Sandonato L et al (2009) Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: An immunohistochemical study. Ann N Y Acad Sci 1155:293-299
12. Lok AS, Heathcote EJ, Hoofnagle JH (2001) Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120:1828-1853
13. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS (2007) Management of hepatitis B: Summary of a clinical research workshop. Hepatology 45:1056-1075
14. Mendy ME, Welzel T, Lesi OA et al (2010) Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in the Gambia, West Africa. J Viral Hepat 17:115-122
15. Szczeklik W, Sanak M, Szczeklik A (2004) Functional effects and gender association of COX-2 gene polymorphism G-765 C in bronchial asthma. J Allergy Clin Immunol 114:248-253
16. Saxena A, Prasad KN, Ghoshal UC et al (2008) Polymorphism of -765 G[C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H. pylori infection: A study from northern India. World J Gastroenterol 14:1498-1503
17. Cao B, Chen XP, Zhu P et al (2008) Inhibitory effect of interferon-Alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice. World J Gastroenterol 14:6802-6807
18. Zhang X, Zhang H, Ye L (2006) Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 147:58-66
19. Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG et al (2002) The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-Type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 110:1831-1838
20. Xing LL, Wang ZN, Jiang L et al (2008) Cyclooxygenase 2 polymorphism and colorectal cancer: -765 G[C variant modifies risk associated with smoking and body mass index. World J Gastroenterol 14:1785-1789
21. Sitarz R, Leguit RJ, de Leng WW et al (2008) The COX-2 promoter polymorphism -765 G[C is associated with early-onset, conventional and stump gastric cancers. Mod Pathol 21:685-690
22. Corella D, Gonzalez JI, Bullo M et al (2009) Polymorphisms cyclooxygenase-2-765 G[C and interleukin-6 -174 G[C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts. J Nutr 139:128-134
23. Akkiz Hikmet, Bayram Süleyman, Bekar Aynur, Akgöllü Ersin, Ü lger Yakup (2011) Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma. Mol Cell Biochem 347:201-208
24. Zhu W, Wei BB, Shan X et al (2010) 765 G[C and 8473 T[C polymorphisms of COX-2 and cancer risk: A meta-Analysis based on 33 case-control studies. Mol Biol Rep 37:277-288
25. Hoff JH, te Morsche RH, Roelofs HM et al (2009) COX-2 polymorphisms -765 G ? C and -1195 A ? G and colorectal cancer risk. World J Gastroenterol 15:4561-4565
26. Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M et al (1993) Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 88:39-43